Bowel Project

Bowel Project is a research-led biotechnology company focused on the intersection of the gut microbiome and colorectal health. Spun out of research from Imperial College London, the company leverages advanced metagenomic sequencing and metabolic profiling to develop next-generation diagnostics and precision therapies for bowel diseases. Their primary focus is on identifying microbial signatures associated with colorectal cancer and inflammatory conditions to enable early detection and personalized treatment strategies. By mapping the complex interactions within the gut ecosystem, Bowel Project aims to transform the standard of care for gastrointestinal disorders through microbiome-targeted interventions.